Zura Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Mar '22 Mar 31, 2022
Selling, General & Admin	32.2	30.79	18.64	3.79	1.91
Research & Development	40.37	24.4	44	25.84	45
Operating Expenses	72.57	55.19	62.64	29.63	46.91
Operating Income	-72.57	-55.19	-62.64	-29.63	-46.91
Interest & Investment Income	7.19	8	3.58	0.01	-
Other Non Operating Income (Expenses)	0.28	-5.21	0.74	-0.2	-
EBT Excluding Unusual Items	-65.1	-52.4	-58.32	-29.82	-46.91
Other Unusual Items	-	-	-2.24	-	-
Pretax Income	-65.1	-52.4	-60.56	-29.82	-46.91
Earnings From Continuing Operations	-65.1	-52.4	-60.56	-29.82	-46.91
Minority Interest in Earnings	-	-	0.2	1.74	-
Net Income	-65.1	-52.4	-60.36	-28.08	-46.91
Preferred Dividends & Other Adjustments	-2.58	-7.02	8.88	7.26	-
Net Income to Common	-62.52	-45.39	-69.24	-35.33	-46.91
Shares Outstanding (Basic)	93	75	33	0	-
Shares Outstanding (Diluted)	93	75	33	0	-
Shares Change (YoY)	45.40%	127.05%	14392.36%	-	-
EPS (Basic)	-0.67	-0.60	-2.09	-154.88	-
EPS (Diluted)	-0.67	-0.60	-2.09	-154.88	-
Free Cash Flow	-53.5	-28.15	-15.05	-1.31	-1.68
Free Cash Flow Per Share	-0.57	-0.38	-0.46	-5.75	-
EBITDA	-72.53	-55.18	-	-	-
D&A For EBITDA	0.04	0.01	-	-	-
EBIT	-72.57	-55.19	-62.64	-29.63	-46.91

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q